X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with Unichem Lab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA UNICHEM LAB ELDER PHARMA/
UNICHEM LAB
 
P/E (TTM) x -0.2 32.8 - View Chart
P/BV x 0.1 3.5 2.9% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 ELDER PHARMA   UNICHEM LAB
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
UNICHEM LAB
Mar-16
ELDER PHARMA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs380334 113.8%   
Low Rs188174 108.0%   
Sales per share (Unadj.) Rs491.2146.9 334.3%  
Earnings per share (Unadj.) Rs-3.211.9 -26.8%  
Cash flow per share (Unadj.) Rs14.416.2 89.0%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs376.5105.1 358.2%  
Shares outstanding (eoy) m20.5490.84 22.6%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.61.7 33.4%   
Avg P/E ratio x-89.321.4 -418.0%  
P/CF ratio (eoy) x19.715.7 125.6%  
Price / Book Value ratio x0.82.4 31.2%  
Dividend payout %016.8 0.0%   
Avg Mkt Cap Rs m5,83323,073 25.3%   
No. of employees `000NA5.7 0.0%   
Total wages/salary Rs m2,1792,558 85.2%   
Avg. sales/employee Rs ThNM2,352.5-  
Avg. wages/employee Rs ThNM450.9-  
Avg. net profit/employee Rs ThNM190.4-  
INCOME DATA
Net Sales Rs m10,08913,346 75.6%  
Other income Rs m257192 133.7%   
Total revenues Rs m10,34613,538 76.4%   
Gross profit Rs m-7921,639 -48.3%  
Depreciation Rs m361390 92.6%   
Interest Rs m2,75629 9,570.5%   
Profit before tax Rs m-3,6531,412 -258.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-4 0.0%   
Extraordinary Inc (Exp) Rs m3,713-35 -10,517.6%   
Tax Rs m125293 42.8%   
Profit after tax Rs m-651,080 -6.0%  
Gross profit margin %-7.812.3 -63.9%  
Effective tax rate %-3.420.7 -16.5%   
Net profit margin %-0.68.1 -8.0%  
BALANCE SHEET DATA
Current assets Rs m9,2405,979 154.5%   
Current liabilities Rs m9,9982,432 411.1%   
Net working cap to sales %-7.526.6 -28.3%  
Current ratio x0.92.5 37.6%  
Inventory Days Days4663 73.4%  
Debtors Days Days6060 99.3%  
Net fixed assets Rs m10,1246,403 158.1%   
Share capital Rs m206182 113.2%   
"Free" reserves Rs m5,5829,293 60.1%   
Net worth Rs m7,7349,548 81.0%   
Long term debt Rs m4,889230 2,122.0%   
Total assets Rs m22,88212,843 178.2%  
Interest coverage x-0.350.0 -0.7%   
Debt to equity ratio x0.60 2,619.9%  
Sales to assets ratio x0.41.0 42.4%   
Return on assets %11.88.6 136.2%  
Return on equity %-0.811.3 -7.5%  
Return on capital %22.314.3 155.6%  
Exports to sales %3.029.2 10.4%   
Imports to sales %0.46.3 6.7%   
Exports (fob) Rs m3073,900 7.9%   
Imports (cif) Rs m43847 5.1%   
Fx inflow Rs m3074,356 7.0%   
Fx outflow Rs m1251,162 10.8%   
Net fx Rs m1813,194 5.7%   
CASH FLOW
From Operations Rs m11,7541,119 1,050.3%  
From Investments Rs m-561-853 65.7%  
From Financial Activity Rs m-6,762-334 2,023.3%  
Net Cashflow Rs m4,432-68 -6,488.6%  

Share Holding

Indian Promoters % 39.6 50.1 79.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 15.1 49.7%  
FIIs % 16.8 3.0 560.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 31.7 113.9%  
Shareholders   16,479 20,176 81.7%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   NATCO PHARMA  PLETHICO PHARMA  GLENMARK PHARMA  TORRENT PHARMA  PANACEA BIOTECH  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Close at Record Highs; Bank & Realty Stocks Rally(Closing)

After opening the day marginally higher, Indian share markets extended gains in the afternoon session after the government decided to cut tax rates on certain products and services.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS